标题/作者	年份
Infection in solid-organ transplant recipients JA Fishman New England Journal of Medicine 357 (25), 2601-2614	2007
The middle east respiratory syndrome (MERS) EI Azhar, DSC Hui, ZA Memish, C Drosten, A Zumla Infectious Disease Clinics 33 (4), 891-905	2019
Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial N Singh, DJ Winston, RR Razonable, GM Lyon, FP Silveira, MM Wagener, ... Jama 323 (14), 1378-1387	2020
Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial RK Avery, S Alain, BD Alexander, EA Blumberg, RF Chemaly, ... Clinical Infectious Diseases 75 (4), 690-701	2022
Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence G Haidar, M Boeckh, N Singh The Journal of infectious diseases 221 (Supplement_1), S23-S31	2020
Where do we stand after decades of studying human cytomegalovirus? F Gugliesi, A Coscia, G Griffante, G Galitska, S Pasquero, C Albano, ... Microorganisms 8 (5), 685	2020
Clinical diagnostic testing for human cytomegalovirus infections RR Razonable, N Inoue, SG Pinninti, SB Boppana, T Lazzarotto, ... The Journal of infectious diseases 221 (Supplement_1), S74-S85	2020
Opportunistic infections in transplant patients R Kumar, MG Ison Infectious Disease Clinics 33 (4), 1143-1157	2019
Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and post-transplantation care S Chih, M McDonald, A Dipchand, D Kim, A Ducharme, A Kaan, S Abbey, ... Canadian Journal of Cardiology 36 (3), 335-356	2020
Letermovir as salvage therapy for cytomegalovirus infection in transplant recipients P Phoompoung, VH Ferreira, J Tikkanen, S Husain, A Viswabandya, ... Transplantation 104 (2), 404-409	2020
Covid-19 in kidney transplant recipients: a systematic review of the case series available three months into the pandemic M Oltean, JM Søfteland, J Bagge, J Ekelund, M Felldin, A Schult, ... Infectious Diseases 52 (11), 830-837	2020
Long-term infectious complications of kidney transplantation A Agrawal, MG Ison, L Danziger-Isakov The Clinical Journal of the American Society of Nephrology 17 (2), 286-295	2022
Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice S Scarpini, F Morigi, L Betti, A Dondi, C Biagi, M Lanari Vaccines 9 (6), 551	2021
Outpatient management of the kidney transplant recipient during the SARS-CoV-2 virus pandemic SE Gleeson, RN Formica, EP Marin Clinical Journal of the American Society of Nephrology: CJASN 15 (6), 892	2020
Updates on antiviral drugs for cytomegalovirus prevention and treatment CN Kotton Current Opinion in Organ Transplantation 24 (4), 469-475	2019
Impact of breast milk‐acquired cytomegalovirus infection in premature infants: Pathogenesis, prevention, and clinical consequences? EA Osterholm, MR Schleiss Reviews in medical virology 30 (6), 1-11	2020
CMV prevention and treatment in transplantation: what’s new in 2019 A Stern, GA Papanicolaou Current infectious disease reports 21, 1-11	2019
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events R Rogers, K Saharia, A Chandorkar, ZF Weiss, K Vieira, S Koo, ... BMC infectious diseases 20 (1), 1-11	2020
Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus–positive kidney transplant recipient M Hemmersbach-Miller, BD Alexander, CF Pieper, KE Schmader European Journal of Clinical Microbiology & Infectious Diseases 39 (3), 455-463	2020
Corneal xenotransplantation: Where are we standing? CH Yoon, HJ Choi, MK Kim Progress in retinal and eye research 80, 100876	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。